Impact of early versus late enteral nutrition on cell mediated immunity and its relationship with glucagon like peptide-1 in intensive care unit patients: A prospective study

Critical Care

Volumn 17, Issue 3, 2013, Pages

  Bakiner, Okan ^a   Bozkirli, Emre ^a   Giray, Semih ^a   Arlier, Zulfikar ^a   Kozanoglu, Ilknur ^a   Sezgin, Nurzen ^a   Sariturk, Cagla ^a   Ertorer, Eda ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GLUCAGON LIKE PEPTIDE 1; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASPIRATION PNEUMONIA; BLOOD SAMPLING; CELLULAR IMMUNITY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; ENERGY CONSUMPTION; ENTERIC FEEDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HOSPITAL ADMISSION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LABORATORY TEST; LYMPHOCYTE; MALE; MIDDLE AGED; NASOGASTRIC TUBE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PARENTERAL NUTRITION; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SINGLE BLIND PROCEDURE; STOMACH INTUBATION; THROMBOEMBOLISM; UNIVERSITY HOSPITAL; BLOOD; COMPARATIVE STUDY; PHYSIOLOGY; PROCEDURES; TIME; TRENDS;

AGED; BIOLOGICAL MARKERS; ENTERAL NUTRITION; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; IMMUNITY, CELLULAR; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 84879088221     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12795     Document Type: Article

References (40)

1. Jolliet P, Pichard C, Biolo G, Chioléro R, Grimble G, Leverve X, Nitenberg G, Novak I, Planas M, Preiser JC, Roth E, Schols AM, Wernerman J. Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine. Intensive Care Med 1998, 24:848-859. 10.1007/s001340050677, 9757932.
2. Doig GS, Simpson F. Early enteral nutrition in the critically ill: do we need more evidence or better evidence?. Curr Opin Crit Care 2006, 12:126-130. 10.1097/01.ccx.0000216579.34310.84, 16543788.
3. Simpson F, Doig GS. Parenteral vs. enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle. Intensive Care Med 2005, 31:12-23. 10.1007/s00134-004-2511-2, 15592814.
4. Martin CM, Doig GS, Heyland DK, Morrison T, Sibbald WJ. Southwestern Ontario Critical Care Research Network. Multicentre, cluster-randomized clinical trial of algorithms for critical-care enteral and parenteral therapy (ACCEPT). CMAJ 2004, 170:197-204. 315525, 14734433.
5. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P, Canadian Critical Care Clinical Practice Guidelines Committee Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 2003, 27:355-373. 10.1177/0148607103027005355, 12971736, Canadian Critical Care Clinical Practice Guidelines Committee.
6. Ibrahim EH, Mehringer L, Prentice D, Sherman G, Schaiff R, Fraser V, Kollef MH. Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 2002, 26:174-181. 10.1177/0148607102026003174, 12005458.
7. Kattelmann KK, Hise M, Russell M, Charney P, Stokes M, Compher C. Preliminary evidence for a medical nutrition therapy protocol: enteral feedings for critically ill patients. J Am Diet Assoc 2006, 106:1226-1241. 10.1016/j.jada.2006.05.320, 16863719.
8. Deacon CF. What do we know about the secretion and degradation of incretin hormones?. Regul Pept 2005, 128:117-124. 10.1016/j.regpep.2004.06.007, 15780431.
9. Kim SJ, Nian C, Doudet DJ, McIntosh CH. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation. Diabetes 2009, 58:641-651. 2646063, 19073764.
10. Xue S, Wasserfall CH, Parker M, Brusko TM, McGrail S, McGrail K, Moore M, Campbell-Thompson M, Schatz DA, Atkinson MA, Haller MJ. Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cellfrequency. Ann NY Acad Sci 2008, 1150:152-156. 10.1196/annals.1447.049, 19120286.
11. Hadjiyanni I, Siminovitch KA, Danska JS, Drucker DJ. Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells. Diabetologia 2010, 53:730-740. 10.1007/s00125-009-1643-x, 20225396.
12. Chatila TA. Regulatory T cells: key players in tolerance and autoimmunity. Endocrinol Metab Clin North Am 2009, 38:265-272. 10.1016/j.ecl.2009.01.002, 2700045, 19328410.
13. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 2009, 7:97. 10.1186/1479-5876-7-97, 2780998, 19919699.
14. Spilker J, Kongable G, Barch C, Braimah J, Brattina P, Daley S, Donnarumma R, Rapp K, Sailor S. Using the NIH Stroke Scaleto assess stroke patients. The NINDS rt-PA Stroke Study Group. J Neuro Sci Nurs 1997, 29:384-392.
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis ACCP/SCCM consensus conference committee. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
16. Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, Nitenberg G, van den Berghe G, Wernerman J, , Ebner C, Hartl W, Heymann C, Spies C, DGEM (GermanSocietyforNutritionalMedicine), ESPEN (European Society for Parenteral and Enteral Nutrition) ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr 2006, 25:210-223. 10.1016/j.clnu.2006.01.021, 16697087, DGEM (GermanSocietyforNutritionalMedicine), ESPEN (European Society for Parenteral and Enteral Nutrition).
17. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C, ESPEN ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009, 28:387-400. 10.1016/j.clnu.2009.04.024, 19505748, ESPEN.
18. Doig GS, Simpson F, Finfer S, Delaney A, Davies AR, Mitchell I, Dobb G. Nutrition guidelines investigators of the ANZICS clinical trials group. Effect of evidence-based feeding guidelines on mortality of critically ill adults: a cluster randomized controlled trial. JAMA 2008, 300:2731-2741. 10.1001/jama.2008.826, 19088351.
19. Host JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007, 87:1409-1439. 10.1152/physrev.00034.2006, 17928588.
20. Gupta V. Pleiotropic effects of incretins. Indian J Endocrinol Metab 2012, 16(Suppl1):S47-56. 3354942, 22701844.
21. Salcedo I, Tweedie D, Li Y, Greig NH. Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders. Br J Pharmacol 2012, 166:1586-1599. 10.1111/j.1476-5381.2012.01971.x, 3419902, 22519295.
22. Chowen JA, de Fonseca FR, Alvarez E, Navarro M, García-Segura LM, Blázquez E. Increased glucagon-like peptide-1 receptorexpression in glia after mechanical lesion of the rat brain. Neuropeptides 1999, 33:212-215. 10.1054/npep.1999.0757, 10657494.
23. Lee CH, Yan B, Yoo KY, Choi JH, Kwon SH, Her S, Sohn Y, Hwang IK, Cho JH, Kim YM, Won MH. Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia. J Neurosci Res 2011, 89:1103-1113. 10.1002/jnr.22596, 21472764.
24. Li Y, Perry T, Kindy MS, Harvey BK, Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, Brossi A, Lahiri DK, Mattson MP, Hoffer BJ, Wang Y, Greig NH. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci USA 2009, 106:1285-1290. 10.1073/pnas.0806720106, 2633544, 19164583.
25. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V. Glucagon-like peptide-1 (7-36) amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 1993, 138:159-166. 10.1677/joe.0.1380159, 7852887.
26. Rijkelijkhuizen JM, McQuarrie K, Girman CJ, Stein PP, Mari A, Holst JJ, Nijpels G, Dekker JM. Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses. Metabolism 2010, 59:502-511. 10.1016/j.metabol.2009.07.039, 19846181.
27. Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 2003, 88:2706-2713. 10.1210/jc.2002-021873, 12788877.
28. Llompart-Pou JA, Fernández-de-Castillo AG, Burguera B, Pérez-Bárcena J, Marsé P, Rodríguez-Yago M, Barceló A, Raurich JM. Stress hyperglycaemia in critically ill patients: potential role of incretin hormones; a preliminary study. Nutr Hosp 2012, 27:130-137.
29. Jensen DH, Aaboe K, Henriksen JE, Vølund A, Holst JJ, Madsbad S, Krarup T. Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes. Diabetologia 2012, 55:1406-1416. 10.1007/s00125-012-2459-7, 22286551.
30. Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK. Reduced glucose tolerance and insülin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. J Clin Endocrinol Metab 2010, 95:3309-3317. 10.1210/jc.2010-0119, 20410219.
31. Deane AM, Chapman MJ, Fraser RJ, Burgstad CM, Besanko LK, Horowitz M. The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blindplacebo-controlled crossover study. Crit Care 2009, 13:R67. 10.1186/cc7874, 2717426, 19439067.
32. Hall JE. Guyton and Hall Textbook of Medical Physiology 2010, 220-224. Philadelphia: Saunders Publishing, 12.
33. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R. Regulatory T cells are key cerebroprotective immune-modulators in acute experimental stroke. Nat Med 2009, 15:192-199. 10.1038/nm.1927, 19169263.
34. Long KZ, Nanthakumar N. Energetic and nutritional regulation of the adaptive immune response and trade-offs in ecological immunology. Am J Hum Biol 2004, 16:499-507. 10.1002/ajhb.20064, 15368598.
35. Kemen M, Senkal M, Homann HH, Mumme A, Dauphin AK, Baier J, Windeler J, Neumann H, Zumtobel V. Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med 1995, 23:652-659. 10.1097/00003246-199504000-00012, 7536138.
36. Artinian V, Krayem H, DiGiovine B. Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest 2006, 129:960-967. 10.1378/chest.129.4.960, 16608945.
37. Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H, Khazaie K. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci USA 2005, 102:419-424. 10.1073/pnas.0408197102, 544311, 15623559.
38. Mempel TR, Pittet MJ, Khazaie K, Weninger W, Weissleder R, von Boehmer H, von Andrian UH. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 2006, 25:129-141. 10.1016/j.immuni.2006.04.015, 16860762.
39. Deane AM, Chapman MJ, Fraser RJ, Summers MJ, Zaknic AV, Storey JP, Jones KL, Rayner CK, Horowitz M. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia. Crit Care Med 2010, 38:1261-1269.
40. Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011, 365:506-517. 10.1056/NEJMoa1102662, 21714640.